AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33017685 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrograde filling of the bladder with 200 mL of saline before catheter removal
Number of subjects: 42
Study 33017685 — intervention group
Group type: COMPARATOR
Intervention: Standard care (immediate catheter removal)
Number of subjects: 42
Study 33017685 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 34376488 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic valve calcification (AVC) scores
Number of subjects: 14073
Study 34376488 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular risk factors
Number of subjects: 14073
Study 32856785 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative concurrent aerobic and resistance training for 12 weeks
Number of subjects: 49
Study 32856785 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 49
Study 36079794 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g/day n3-PUFA
Number of subjects: 63
Study 36079794 — intervention group
Group type: COMPARATOR
Intervention: Corn oil placebo
Number of subjects: 63
Study 33162260 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 14
Study 32205572 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane blocks
Number of subjects: 90
Study 32205572 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral blocks
Number of subjects: 90
Study 32205572 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 90
Study 35598544 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg of saccharin
Number of subjects: 9
Study 35598544 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g of sucrose
Number of subjects: 9
Study 35598544 — intervention group
Group type: COMPARATOR
Intervention: 300 ml of water
Number of subjects: 9
Study 32240035 — intervention group
Group type: EXPERIMENTAL
Intervention: TaTME
Number of subjects: 38
Study 32240035 — intervention group
Group type: COMPARATOR
Intervention: LapTME
Number of subjects: 38
Study 32308200 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-month exercise training programme
Number of subjects: 90
Study 32308200 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 90
Study 35657320 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA-guided management
Number of subjects: 455
Study 35657320 — intervention group
Group type: COMPARATOR
Intervention: standard management
Number of subjects: 455
Study 35657320 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA-positive patients receiving adjuvant chemotherapy
Number of subjects: 455
Study 35657320 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA-negative patients not receiving adjuvant chemotherapy
Number of subjects: 455
Study 32528151 — intervention group
Group type: EXPERIMENTAL
Intervention: Identical meals
Number of subjects: 1002
Study 32528151 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut microbiome
Number of subjects: 1002
Study 32528151 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal macronutrients
Number of subjects: 1002
Study 32528151 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants
Number of subjects: 1002
Study 32528151 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning model
Number of subjects: 1002
Study 35487736 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of light acupuncture treatment and five-element music therapy
Number of subjects: 36
Study 35487736 — intervention group
Group type: COMPARATOR
Intervention: No treatment group
Number of subjects: 36
Study 33852330 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy CT (DECT)-based nomogram
Number of subjects: 206
Study 34809440 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 40
Study 34548372 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-bias modification intervention (12-session training programme over 3 weeks)
Number of subjects: 308
Study 34548372 — intervention group
Group type: COMPARATOR
Intervention: Control condition (placebo)
Number of subjects: 308
Study 32248820 — intervention group
Group type: EXPERIMENTAL
Intervention: systematic maintenance rTMS (M-rTMS) for responders (arm A)
Number of subjects: 318
Study 32248820 — intervention group
Group type: EXPERIMENTAL
Intervention: additional new rTMS cure in case of mood deterioration among responders (arm B)
Number of subjects: 318
Study 32248820 — intervention group
Group type: COMPARATOR
Intervention: placebo arm (arm C)
Number of subjects: 318
Study 36153330 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-653 0.5 mg
Number of subjects: 24
Study 36153330 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-653 6 mg
Number of subjects: 24
Study 36153330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 32866238 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine exposure from nonstaff NICU visitors' fingers
Number of subjects: 210
Study 32866238 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside furniture nicotine contamination
Number of subjects: 210
Study 32866238 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant cotinine measures
Number of subjects: 210
Study 32866238 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with household nicotine use
Number of subjects: 210
Study 32866238 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian univariate regressions
Number of subjects: 210
Study 33433363 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipated delay in help-seeking for persistent cough
Number of subjects: 1895
Study 33433363 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipated delay in help-seeking for rectal bleeding
Number of subjects: 1895
Study 33433363 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipated delay in help-seeking for breast changes
Number of subjects: 1895
Study 35210132 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 mg lenvatinib plus everolimus 5 mg/d
Number of subjects: 0
Study 35210132 — intervention group
Group type: COMPARATOR
Intervention: 18 mg lenvatinib plus everolimus 5 mg/d
Number of subjects: 0
Study 32844806 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding group
Number of subjects: 50
Study 34398312 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercises in a 33 °C spa pool, 5 days a week for 2 weeks, 20 min per day
Number of subjects: 43
Study 34398312 — intervention group
Group type: COMPARATOR
Intervention: Non-aquatic exercises (walking out of the pool and strengthening/stretching exercises), 5 days a week for 2 weeks, 20 min per day
Number of subjects: 43
Study 33294894 — intervention group
Group type: EXPERIMENTAL
Intervention: Education-Based Intervention Program (EBIP)
Number of subjects: 40
Study 33294894 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 40
Study 34146510 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% ONS stimulation
Number of subjects: 150
Study 34146510 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% ONS stimulation
Number of subjects: 150
Study 34146510 — intervention group
Group type: COMPARATOR
Intervention: Both 100% and 30% ONS
Number of subjects: 150
Study 33835414 — intervention group
Group type: EXPERIMENTAL
Intervention: ReQoL-UI/10
Number of subjects: 361
Study 33835414 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L (VSE/cross-walk scores)
Number of subjects: 361
Study 33835414 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L (VSE)
Number of subjects: 361
Study 33835414 — intervention group
Group type: EXPERIMENTAL
Intervention: ReQoL-10
Number of subjects: 361
Study 33835414 — intervention group
Group type: EXPERIMENTAL
Intervention: ReQoL-UI
Number of subjects: 361
Study 33835414 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 361
Study 35346229 — intervention group
Group type: EXPERIMENTAL
Intervention: High Personalisation (HP) - access to ‘BBB’ website, video coaching sessions, text message support
Number of subjects: 83
Study 35346229 — intervention group
Group type: COMPARATOR
Intervention: Medium Personalisation (MP) - website and text message support
Number of subjects: 83
Study 35346229 — intervention group
Group type: COMPARATOR
Intervention: Low Personalisation (LP) - website only
Number of subjects: 83
Study 33626290 — intervention group
Group type: EXPERIMENTAL
Intervention: Dengue vaccine booster
Number of subjects: 0
Study 33626290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32450831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of carbosulfan or profenofos
Number of subjects: 337
Study 32450831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of pesticides
Number of subjects: 337
Study 32450831 — intervention group
Group type: EXPERIMENTAL
Intervention: Trend analysis of carbosulfan and profenofos
Number of subjects: 337
Study 35797300 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin 5% and Fusidic acid 2% cream
Number of subjects: 40
Study 35797300 — intervention group
Group type: COMPARATOR
Intervention: Permethrin 5% and placebo
Number of subjects: 40
Study 34054104 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐μg E2 vaginal insert
Number of subjects: 75
Study 34054104 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐μg E2 vaginal insert
Number of subjects: 75
Study 34054104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 32762415 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (first-line treatment)
Number of subjects: 302
Study 35641166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal (IT) transplantation of mesenchymal stem cells (MSC)
Number of subjects: 48
Study 35641166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) transplantation of mesenchymal stem cells (MSC)
Number of subjects: 48
Study 35641166 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham treatment)
Number of subjects: 48
Study 34377204 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous eptifibatide before angioplasty with heparin
Number of subjects: 104
Study 34377204 — intervention group
Group type: COMPARATOR
Intervention: Coronary angioplasty with heparin
Number of subjects: 104
Study 32047021 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative management
Number of subjects: 0
Study 32047021 — intervention group
Group type: COMPARATOR
Intervention: Non-operative management
Number of subjects: 0
Study 36034460 — intervention group
Group type: EXPERIMENTAL
Intervention: LH-based modified GnRH antagonist protocol
Number of subjects: 372
Study 36034460 — intervention group
Group type: COMPARATOR
Intervention: Conventional flexible GnRH antagonist protocol
Number of subjects: 372
Study 36034460 — intervention group
Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 372
Study 34351363 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-week multicomponent intervention
Number of subjects: 383
Study 34351363 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 383
Study 33238932 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness oriented intervention (6 weeks of mindfulness training combined with interactive drug education)
Number of subjects: 82
Study 33238932 — intervention group
Group type: COMPARATOR
Intervention: Control group (health training combined with the same education)
Number of subjects: 82
Study 33238932 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness oriented intervention
Number of subjects: 82
Study 35421939 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR-guided workflow
Number of subjects: 100
Study 35421939 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR-aided workflow
Number of subjects: 100
Study 35421939 — intervention group
Group type: COMPARATOR
Intervention: Standard EAM-guided VT ablation
Number of subjects: 100
Study 35421939 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR-guided vs CMR-aided approaches
Number of subjects: 100
Study 34755786 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded Spurs (BS)
Number of subjects: 63
Study 34755786 — intervention group
Group type: EXPERIMENTAL
Intervention: Chincup (CC)
Number of subjects: 63
Study 34755786 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed Palatal Crib (FPC)
Number of subjects: 63
Study 34755786 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable Palatal Crib (RPC)
Number of subjects: 63
Study 33050586 — intervention group
Group type: EXPERIMENTAL
Intervention: 320 mg of Fermented Porcine Placental Extract (FPP) once daily
Number of subjects: 84
Study 33050586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 35037125 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 1226
Study 35037125 — intervention group
Group type: COMPARATOR
Intervention: Succinylcholine
Number of subjects: 1226
Study 35037125 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI > 30 kg/m2
Number of subjects: 1226
Study 35037125 — intervention group
Group type: EXPERIMENTAL
Intervention: SpO2 < 90% before intubation
Number of subjects: 1226
Study 35037125 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation Difficulty Score > 5
Number of subjects: 1226
Study 35037125 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intubation hypoxaemia
Number of subjects: 1226
Study 35037125 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intubation hypotension
Number of subjects: 1226
Study 35037125 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary aspiration
Number of subjects: 1226
Study 34117637 — intervention group
Group type: EXPERIMENTAL
Intervention: Study medication (specifics not provided)
Number of subjects: 22
Study 36327514 — intervention group
Group type: EXPERIMENTAL
Intervention: Binaural music (BM)
Number of subjects: 60
Study 36327514 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-binaural music (NBM)
Number of subjects: 60
Study 36327514 — intervention group
Group type: COMPARATOR
Intervention: Standard care (C)
Number of subjects: 60
Study 33397282 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved cookstove intervention
Number of subjects: 2031
Study 33397282 — intervention group
Group type: COMPARATOR
Intervention: Traditional cookstove method (Control)
Number of subjects: 2031
Study 35644753 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention
Number of subjects: 75
Study 35644753 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 75
Study 34283660 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-load intensity RT (HIRT, n = 20, 8-12 repetition maximum)
Number of subjects: 40
Study 34283660 — intervention group
Group type: COMPARATOR
Intervention: Lower-load intensity RT (LIRT, n = 20, 30-35 repetition maximum)
Number of subjects: 40
Study 32212806 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender essential oil on a cotton ball
Number of subjects: 80
Study 32212806 — intervention group
Group type: COMPARATOR
Intervention: Distilled water on a cotton ball (Control)
Number of subjects: 80
Study 35636937 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of melatonin prolonged-release oral capsules
Number of subjects: 0
Study 35636937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34535840 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic matrix and xenograft
Number of subjects: 13
Study 34535840 — intervention group
Group type: COMPARATOR
Intervention: Xenograft
Number of subjects: 13
Study 32689975 — intervention group
Group type: EXPERIMENTAL
Intervention: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) single tablet regimen
Number of subjects: 0
Study 32689975 — intervention group
Group type: COMPARATOR
Intervention: Boosted protease-inhibitor (bPI) regimen
Number of subjects: 0
Study 34831613 — intervention group
Group type: EXPERIMENTAL
Intervention: CReSS device measuring smoking topography (ST) in naturalistic settings for two weeks with five days of device usage.
Number of subjects: 43
Study 34831613 — intervention group
Group type: EXPERIMENTAL
Intervention: CReSS device
Number of subjects: 43
Study 33444178 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week group art therapy intervention
Number of subjects: 240
Study 33444178 — intervention group
Group type: COMPARATOR
Intervention: 8-week Mandala colouring comparison group
Number of subjects: 240
Study 35886420 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised reminder system
Number of subjects: 506
Study 35886420 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 506
Study 34517195 — intervention group
Group type: EXPERIMENTAL
Intervention: High neutrophil-to-lymphocyte ratio (NLR > 2.2)
Number of subjects: 2104
Study 34517195 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of brain metastases (BM)
Number of subjects: 2104
Study 36027380 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting RAS blockers taken on awakening
Number of subjects: 105
Study 36027380 — intervention group
Group type: COMPARATOR
Intervention: Short-acting RAS blockers taken at bedtime
Number of subjects: 105
Study 36027380 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldosterone breakthrough (AB)
Number of subjects: 105
Study 33410611 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 555
Study 33410611 — intervention group
Group type: COMPARATOR
Intervention: Combined volatile anesthetics (sevoflurane and desflurane)
Number of subjects: 555
Study 37759290 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Insulin Delivery (AID) devices
Number of subjects: 2376
Study 34459968 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (ACS)
Number of subjects: 0
Study 34459968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33884645 — intervention group
Group type: EXPERIMENTAL
Intervention: Trophic enteral feeding (20 ml/h) via a nasogastric tube, in addition to standard care.
Number of subjects: 87
Study 33884645 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition care (parenteral nutrition).
Number of subjects: 87
Study 33837106 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiasp
Number of subjects: 220
Study 33837106 — intervention group
Group type: COMPARATOR
Intervention: NovoRapid
Number of subjects: 220
Study 32138596 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression garments (COMP)
Number of subjects: 30
Study 32138596 — intervention group
Group type: COMPARATOR
Intervention: Loose-fitting clothing (CON)
Number of subjects: 30
Study 35720885 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic treatment (observation group)
Number of subjects: 64
Study 35720885 — intervention group
Group type: COMPARATOR
Intervention: Open surgical treatment (control group)
Number of subjects: 64
Study 34742140 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 0
Study 34742140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32648508 — intervention group
Group type: EXPERIMENTAL
Intervention: PDE‐5 inhibitors (PDE‐5i)
Number of subjects: 13772
Study 32648508 — intervention group
Group type: COMPARATOR
Intervention: No PDE‐5 inhibitors (no PDE‐5i)
Number of subjects: 13772
Study 36447250 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Observation Therapy (AOT) combined with eccentric exercises
Number of subjects: 30
Study 36447250 — intervention group
Group type: COMPARATOR
Intervention: Nature videos before performing eccentric exercises (Control)
Number of subjects: 30
Study 33865711 — intervention group
Group type: EXPERIMENTAL
Intervention: FABIB score (high FABIB scores ≥6)
Number of subjects: 297
Study 33865711 — intervention group
Group type: COMPARATOR
Intervention: Clavien-Dindo Classification (grade III + IV)
Number of subjects: 297
Study 35659064 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg oleoylethanolamide (OEA) capsule daily for 8 weeks
Number of subjects: 46
Study 35659064 — intervention group
Group type: COMPARATOR
Intervention: 125 mg capsule containing wheat flour (placebo) daily for 8 weeks
Number of subjects: 46
Study 32228468 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline slow gait speed
Number of subjects: 369
Study 32228468 — intervention group
Group type: EXPERIMENTAL
Intervention: Incident slow gait speed at 18 months
Number of subjects: 369
Study 32228468 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive severity at baseline
Number of subjects: 369
Study 34045217 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication review at hospital discharge combined with communication stimulus between hospital physicians and general practitioners
Number of subjects: 612
Study 34045217 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 612
Study 32237922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry supplement (288 mg equivalent to 26 g of dried cranberry)
Number of subjects: 41
Study 32237922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 34358756 — intervention group
Group type: EXPERIMENTAL
Intervention: CBM‐IClin (Cognitive Bias Modification-Interpretation program)
Number of subjects: 121
Study 34358756 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 121
Study 33051212 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist led outpatient rehabilitation (18 sessions over six weeks)
Number of subjects: 334
Study 33051212 — intervention group
Group type: COMPARATOR
Intervention: Home exercise based protocol (physiotherapy review followed by home exercises)
Number of subjects: 334
Study 35703569 — intervention group
Group type: EXPERIMENTAL
Intervention: Homemade orange corn-soybean flour (H-CSB)
Number of subjects: 101
Study 35703569 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange corn-common bean flour (CCBB)
Number of subjects: 101
Study 35703569 — intervention group
Group type: COMPARATOR
Intervention: Commercial corn-soybean flour (C-CSB)
Number of subjects: 101
Study 32959182 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D HD
Number of subjects: 21
Study 32959182 — intervention group
Group type: EXPERIMENTAL
Intervention: 4K HD
Number of subjects: 21
Study 32959182 — intervention group
Group type: COMPARATOR
Intervention: 2D HD
Number of subjects: 21
Study 32861156 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple locus variable number tandem repeat analysis (MLVA)
Number of subjects: 60